BrightInsight Announces Partnership with Sanofi to Bring to Market a Next Generation Digital Companion App
The BrightInsight Platform was selected to accelerate development of one of Sanofi’s Best-In-Class Software as a Medical Device.
Learn More
BrightInsight accelerates time to market for our customers’ digital health products, including apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD) across therapeutic areas.
The BrightInsight Platform was selected to accelerate development of one of Sanofi’s Best-In-Class Software as a Medical Device.
Learn More
Led by General Catalyst, the Financing will Fuel BrightInsight’s Hypergrowth as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech
Learn More
CSL Behring selects the BrightInsight Platform to build and manage its digital health solutions within a regulatory-compliant environment.
Learn More
Watch an on-demand webinar with Paul Upham, Head of Smart Devices at Roche/Genentech, where he discusses how Roche launched a regulated SaMD dosing calculator for treating hemophilia A in Europe.
Download
Using a regulated infrastructure alleviates regulatory concerns as you’re developing your product over years and years. You can be confident that from an infrastructure standpoint, you’ll be compliant.
- Bradley Merrill Thompson, Epstein Becker & Green, P.C.